Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 for SGA-induced Metabolic Syndrome in Bipolar Youth
NCT01858948Phase 3Completed
- Sponsor
- University of Cincinnati
- Start
- Jul 2013
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of OmegaRx in metabolic syndrome, hypertriglyceridemia, sponsored by University of Cincinnati. Started Jul 2013; status: completed.
02
Drugs
OmegaRx
03
Conditions
metabolic syndromehypertriglyceridemia
Beyond the preview
Go deeper on NCT01858948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01858948.